Logo image of CN.CA

CONDOR RESOURCES INC (CN.CA) Stock Fundamental Analysis

TSX-V:CN - TSX Venture Exchange - CA20676U1049 - Common Stock - Currency: CAD

0.13  0 (0%)

Fundamental Rating

2

Taking everything into account, CN scores 2 out of 10 in our fundamental rating. CN was compared to 806 industry peers in the Metals & Mining industry. While CN has a great health rating, there are worries on its profitability. CN has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

CN had negative earnings in the past year.
CN had a negative operating cash flow in the past year.
Of the past 5 years CN 4 years were profitable.
In the past 5 years CN always reported negative operating cash flow.
CN.CA Yearly Net Income VS EBIT VS OCF VS FCFCN.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2M -2M -4M

1.2 Ratios

CN has a Return On Assets of -80.03%. This is in the lower half of the industry: CN underperforms 71.84% of its industry peers.
The Return On Equity of CN (-83.10%) is worse than 63.40% of its industry peers.
Industry RankSector Rank
ROA -80.03%
ROE -83.1%
ROIC N/A
ROA(3y)-20.76%
ROA(5y)-4.33%
ROE(3y)-21.69%
ROE(5y)-4.68%
ROIC(3y)N/A
ROIC(5y)N/A
CN.CA Yearly ROA, ROE, ROICCN.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -50 -100

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for CN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CN.CA Yearly Profit, Operating, Gross MarginsCN.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

7

2. Health

2.1 Basic Checks

The number of shares outstanding for CN remains at a similar level compared to 1 year ago.
CN has more shares outstanding than it did 5 years ago.
There is no outstanding debt for CN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CN.CA Yearly Shares OutstandingCN.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M
CN.CA Yearly Total Debt VS Total AssetsCN.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M 10M

2.2 Solvency

An Altman-Z score of 47.46 indicates that CN is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 47.46, CN belongs to the top of the industry, outperforming 87.59% of the companies in the same industry.
CN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 47.46
ROIC/WACCN/A
WACCN/A
CN.CA Yearly LT Debt VS Equity VS FCFCN.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2M -2M 4M 6M 8M 10M

2.3 Liquidity

A Current Ratio of 1.38 indicates that CN should not have too much problems paying its short term obligations.
CN has a Current ratio (1.38) which is comparable to the rest of the industry.
CN has a Quick Ratio of 1.38. This is a normal value and indicates that CN is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.38, CN is in line with its industry, outperforming 50.99% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.38
Quick Ratio 1.38
CN.CA Yearly Current Assets VS Current LiabilitesCN.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1M 2M 3M 4M

0

3. Growth

3.1 Past

CN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -481.82%.
EPS 1Y (TTM)-481.82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-7450%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CN.CA Yearly Revenue VS EstimatesCN.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 1B 2B 3B 4B

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CN. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CN.CA Price Earnings VS Forward Price EarningsCN.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CN.CA Per share dataCN.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.02 -0.02

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for CN!.
Industry RankSector Rank
Dividend Yield N/A

CONDOR RESOURCES INC

TSX-V:CN (7/31/2025, 7:00:00 PM)

0.13

0 (0%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)07-29 2025-07-29
Earnings (Next)10-21 2025-10-21
Inst Owners18.23%
Inst Owner ChangeN/A
Ins Owners12.23%
Ins Owner ChangeN/A
Market Cap19.49M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 3.42
P/tB 3.42
EV/EBITDA N/A
EPS(TTM)-0.03
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0
BVpS0.04
TBVpS0.04
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -80.03%
ROE -83.1%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-20.76%
ROA(5y)-4.33%
ROE(3y)-21.69%
ROE(5y)-4.68%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.38
Quick Ratio 1.38
Altman-Z 47.46
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-481.82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-7450%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-137.36%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y23.46%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-84.78%
OCF growth 3YN/A
OCF growth 5YN/A